The Obesity Medicine Association has partnered and will be partnering with several external education companies to co-develop and launch new, interactive education focused on obesity medicine.
These courses are accredited by our partners and available for free on their web pages.
Pri-Med Partnership | Current Issues in Obesity: Stigma, Science, and Solutions
Pri-Med provides continuing education to thousands of primary care clinicians throughout the United States. As a trusted source of continuing education in obesity medicine, Pri-Med collaborated with OMA to co-develop a course, “Current Issues in Obesity: Stigma and Solutions” to educate primary care providers on the diagnosis and treatment of obesity.
Management of patients with obesity can be challenging but is an essential skill for primary care clinicians as the rates of obesity continue to rise in the United States. In addition to the PrimaryCareNOW webcast, check out the 4 short modules below that are designed with interactive features to enhance your learning and keep you engaged. Complete all the modules in this focused obesity curriculum to help you do the following in your clinical practice.
1. Recognize obesity as a serious chronic illness that requires long-term management to reduce and prevent comorbid conditions
2. Discuss underlying physiologic factors influencing obesity such as metabolic adaptation that contribute to difficulty in weight management along with the struggle to sustain lifestyle interventions
3. Review clinician bias surrounding obesity and discuss ways to reduce stigma and bias to improve the patient experience
4. Develop individualized, long-term obesity management plans utilizing current and emerging pharmacotherapies
Credits: 2.50 AMA PRA Category 1 Credits™, 2.50 ABIM MOC or 2.56 AANP, including 0.75 AANP Pharm
Cost: Free for OMA members and non-members
Paradigm Medical Communications, LLC Partnership | Current Approaches to Managing Patients with Obesity
Current Approaches to Managing Patients with Obesity: Considering Weight Loss, Comorbidities, Pharmacotherapy, and Complications